ストックスクリーナーアプリを入手
63.54
2.38%
-1.55
Corcept Therapeutics Inc (CORT) 最新ニュース
Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Blue Trust Inc. Sells 8,728 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Van ECK Associates Corp Purchases New Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Reaches New 12-Month HighWhat's Next? - MarketBeat
Corcept stock down on California lawsuit (CORT:NASDAQ) - Seeking Alpha
Corcept Therapeutics stock soars to all-time high of $71.3 - MSN
New York State Teachers Retirement System Acquires 3,789 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
New York State Teachers Retirement System Purchases 3,789 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Roman Butler Fullerton & Co. Grows Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Big health insurers sue Peninsula company over its lone drug - The Business Journals
Corcept Therapeutics stock soars to all-time high of $62.34 - MSN
Van ECK Associates Corp Makes New Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Allspring Global Investments Holdings LLC Has $10.60 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Abortion Drugs Market Generated Opportunities, Future Scope - openPR
Braun Stacey Associates Inc. Invests $14.94 Million in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Certuity LLC Takes $204,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
HC Wainwright Has Optimistic Outlook of CORT Q1 Earnings - MarketBeat
Corcept Submits Application for Another Cushing's Syndrome Drug - MSN
Corcept Therapeutics (NASDAQ:CORT) Hits New 1-Year HighHere's Why - MarketBeat
Corcept Therapeutics Incorporated (NASDAQ:CORT) Director Daniel N. Swisher, Jr. Sells 2,200 Shares - MarketBeat
At Corcept Therapeutics, Hazel Hunt Chooses To Exercise Options, Resulting In $10.61M - Benzinga
H.C. Wainwright lifts Corcept stock target to $115 on drug outlook - MSN
Corcept therapeutics director sells shares worth $149,776 - MSN
Corcept therapeutics director Daniel Swisher sells shares worth $149,776 By Investing.com - Investing.com South Africa
Yousif Capital Management LLC Sells 516 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Corcept therapeutics director sells shares worth $149,776 By Investing.com - Investing.com Canada
Corcept therapeutics director Daniel Swisher sells shares worth $149,776 - MSN
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call - Yahoo Finance
Research Analysts Issue Forecasts for CORT FY2029 Earnings - MarketBeat
abrdn plc Has $21.97 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
HC Wainwright Reaffirms Buy Rating for Corcept Therapeutics (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics’ (CORT) “Buy” Rating Reiterated at HC Wainwright - Defense World
Calamos Advisors LLC Sells 4,908 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Boston Trust Walden Corp Lowers Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
H.C. Wainwright maintains $80 target on Corcept Therapeutics stock - MSN
Corcept Therapeutics Inc (CORT) Stock Sees a-0.60 Decrease - The News Heater
H.C. Wainwright maintains $80 target on Corcept Therapeutics stock By Investing.com - Investing.com UK
Q3 EPS Forecast for Corcept Therapeutics Raised by Analyst - MarketBeat
Endogenous Cushing's Syndrome Market Statistics Expected - openPR
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):